The Psychedelics Newsletter

Landmark UK trial to investigate psilocybin for opioid addiction relapse

Psilocybin versus escitalopram for depression shows positive results

Psilocybin versus escitalopram for depression shows positive results

Shortwave Life Sciences psilocybin drug shows positive results in anorexia trial

Drug Science and UCL to tackle FDA concerns on therapy component of MDMA treatment

Major deals continue positive trajectory for psychedelics in 2024, Psychedelics could treat chronic pain, MDMA research comes under scrutiny